(Q35163801)

6 August 2017

1 reference

title

Advances in alcoholic liver disease. (English)

1 reference

6 August 2017

Gavin Arteel

1

1 reference

6 August 2017

Luis Marsano

2

1 reference

6 August 2017

Christian Mendez

3

1 reference

6 August 2017

Frederick Bentley

4

1 reference

6 August 2017

Craig J McClain

5

1 reference

6 August 2017

publication date

1 August 2003

1 reference

Best Practice and Research: Clinical Gastroenterology

6 August 2017

published in

1 reference

6 August 2017

volume

17

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

625-647

1 reference

Mortality of alcohol abusing men prospectively assessed in relation to history of abuse and degree of liver injury

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Prognosis and life expectancy in chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Alcohol consumption and mortality among women.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Alcohol consumption and mortality among middle-aged and elderly U.S. adults

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Epidemiology of alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Interobserver agreement in the physical diagnosis of alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Utility and evaluation of biochemical markers of alcohol consumption

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Screening for Drinking Disorders in the Elderly Using the CAGE Questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Fatty liver: a study of 270 patients with biopsy proven fatty liver and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Factors determining cirrhosis in alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Histological course of alcoholic hepatitis. Influence of abstinence, sex and extent of hepatic damage

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Carbohydrate-deficient transferrin and other markers of high alcohol consumption: a study of 502 patients admitted consecutively to a medical department

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

The SGOT/SGPT ratio?An indicator of alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Screening for excessive alcohol drinking. Comparative value of carbohydrate-deficient transferrin, gamma-glutamyltransferase, and mean corpuscular volume

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

New alcohol markers--how useful are they in population studies: the Svalbard Study 1988-89

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Gamma-glutamyltranspeptidase and carbohydrate deficient transferrin: alternative measures of excessive alcohol consumption

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Cytokines and alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes?

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Diagnostic value of liver biopsy in alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Hepatic mitochondrial DNA deletion in alcoholics: association with microvesicular steatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Histologic spectrum of alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Significance of megamitochondria in alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Metabolic effects of acetaldehyde

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Distribution of ethanol-induced protein adducts in vivo: relationship to tissue injury

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

The effect of ethanol-induced cytochrome p4502E1 on the inhibition of proteasome activity by alcohol.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1)

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

CYP2E1-dependent toxicity and oxidative stress in HepG2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

The CYP2E1 knockout delivers another punch: first ASH, now NASH. Alcoholic steatohepatitis. Nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

ALCOHOL: its metabolism and interaction with nutrients

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Hepatic steatosis: innocent bystander or guilty party?

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Alcohol, malnutrition, and alcoholic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

The effects of alcohol consumption upon the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Ebselen prevents early alcohol-induced liver injury in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Increased lipid peroxidation and impaired antioxidant enzyme function is associated with pathological liver injury in experimental alcoholic liver disease in rats fed diets high in corn oil and fish oil

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Delivery of the Cu/Zn-superoxide dismutase gene with adenovirus reduces early alcohol-induced liver injury in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Overexpression of manganese superoxide dismutase prevents alcohol-induced liver injury in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Superoxide radical and superoxide dismutases

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Myeloperoxidase-halide-hydrogen peroxide antibacterial system

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Nitric oxide in liver diseases: friend, foe, or just passerby?

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Endogenous nitric oxide attenuates ethanol-induced perturbation of hepatic circulation in the isolated perfused rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Nitric oxide prevents tumor necrosis factor alpha-induced rat hepatocyte apoptosis by the interruption of mitochondrial apoptotic signaling through S-nitrosylation of caspase-8.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Impaired liver regeneration in inducible nitric oxide synthasedeficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Experimental liver cirrhosis induced by alcohol and iron

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

The ubiquitin-proteasome system and its role in ethanol-induced disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Oxidative stress and gene regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Free radicals in the physiological control of cell function

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Redox signaling in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Redox regulation of cellular signalling

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Calcium and oxidative stress: from cell signaling to cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Oxidants as stimulators of signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Oxygen regulation of gene expression: a study in opposites

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Ethanol, oxidative stress, and cytokine-induced liver cell injury

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Depressed hepatic glutathione and increased diene conjugates in alcoholic liver disease. Evidence of lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Increased tumor necrosis factor production by monocytes in alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Increased plasma interleukin-8 concentrations in alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Increased monocyte MCP-1 production in acute alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1alpha in alcoholic liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Monocyte activation in alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Ethanol potentiates tumor necrosis factor-alpha cytotoxicity in hepatoma cells and primary rat hepatocytes by promoting induction of the mitochondrial permeability transition

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Increased cytochrome P-450 2E1 expression sensitizes hepatocytes to c-Jun-mediated cell death from TNF-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

N-acetylcysteine induces cell cycle arrest in hepatic stellate cells through its reducing activity

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Stress-activated protein kinases in the activation of rat hepatic stellate cells in culture.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Role of lipopolysaccharide-binding protein in early alcohol-induced liver injury in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

The Mitochondrial Permeability Transition Augments Fas-induced Apoptosis in Mouse Hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Delivery of IkappaB superrepressor gene with adenovirus reduces early alcohol-induced liver injury in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Cocoa extract protects against early alcohol-induced liver injury in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Cytokines stimulate lipolysis and decrease lipoprotein lipase activity in cultured fat cells by a prostaglandin independent mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

CYTOKINES INHIBIT FATTY ACID OXIDATION IN ISOLATED RAT HEPATOCYTES

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Genetic polymorphisms of alcohol metabolizing enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Alcoholism in hereditary hemochromatosis revisited: prevalence and clinical consequences among homozygous siblings

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Duration of survival in patients with Laennec's cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Alcohol, smoking, coffee, and cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. A case-control study. Provincial Group for the Study of Chronic Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Cigarette smoking and hepatic lesions in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Risk factors of fibrosis in alcohol-induced liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two Veterans Administration Cooperative Studies

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Protein-calorie malnutrition associated with alcoholic hepatitis. Veterans Administration Cooperative Study Group on Alcoholic Hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Dietary treatment of cirrhosis of the liver; results in 124 patients observed during a 10 year period

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Controlled trial on nutrition supplementation in outpatients with symptomatic alcoholic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Nutritional support in alcoholic cirrhotic patients improves host defenses

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Accelerated improvement of alcoholic liver disease with enteral nutrition.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Long-term treatment of alcoholic liver disease with propylthiouracil

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Colchicine in the treatment of cirrhosis of the liver.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Lack of effect of colchicine in alcoholic cirrhosis: final results of a double blind randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

S-adenosylmethionine synthesis: molecular mechanisms and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Interaction of liver methionine adenosyltransferase with hydroxyl radical

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

S-Adenosylmethionine, cytokines, and alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Antioxidants attenuate nuclear factor-kappa B activation and tumor necrosis factor-alpha production in alcoholic hepatitis patient monocytes and rat Kupffer cells, in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Effects of long-term vitamin E supplementation in alcoholic cirrhotics

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Treatment with glutathione precursor decreases cytokine activity

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

The glutathione precursor L-2-oxothiazolidine-4-carboxylic acid protects against liver injury due to chronic enteral ethanol exposure in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Dilinoleoylphosphatidylcholine decreases LPS-induced TNF-alpha generation in Kupffer cells of ethanol-fed rats: respective roles of MAPKs and NF-kappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Indication of liver transplantation in severe alcoholic liver cirrhosis: quantitative evaluation and optimal timing

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Employment and alcohol use after liver transplantation for alcoholic and nonalcoholic liver disease: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Transplantation for alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Long-term follow-up of patients diagnosed with alcohol dependence or alcohol abuse who were evaluated for liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: randomized trials for secondary prophylaxis of variceal bleeding: an updated meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Hepatic Encephalopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

Transjugular intrahepatic portosystemic shunt

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900053-2

7 January 2021

10.1016/S1521-6918(03)00053-2

Identifiers

DOI

1 reference

6 August 2017

1 reference